| Partners |
|
NFCR is supported by literally hundreds of partners, corporate sponsors, and foundations, in addition to individual donors. Here are just a few: Partners Partners
American Airlines and its regional airline partner American Eagle serve almost 250 cities around the world, from Abilene to Zurich, and operate more than 3,600 daily flights. American Airlines is the largest domestic U.S. airline and American Eagle is the largest regional airline system in the world. American Airlines and American Eagle are in business to provide safe, dependable and friendly air transportation to our customers, along with numerous related services. Your safety, comfort, and convenience are our most important concerns. To learn more on how you can earn extra AAdvantage Airmiles AND support cancer research, click HERE.
Botné® Organics is an eco-friendly beauty line based in Irvine, California, dedicated to bringing the highest quality individual ingredients to its products while protecting the environment. Botné® Organics' promise is "enhancing health and beauty naturally." For more information about how you can support NFCR along with Botne' Organics®, please click HERE.
The Asian Fund for Cancer Research, Ltd. (AFCR) is committed to fighting cancer through research into the prevention, diagnosis, and treatment of cancer. AFCR is dedicated to achieving one of medicine's greatest goals: curing cancer to save lives. We fulfill this mission by funding outstanding scientists across Asia who pioneer cancer research and by providing prevention education programs to the general public, as well as patient services assisting those who otherwise cannot access appropriate high-quality cancer treatment. For more information click HERE.
The Chinese Biopharmaceutical Association (CBA) is a non-profit organization of professionals in the areas of bio-pharmaceutical research and technology development. It was established in the Spring of 1995 with its headquarters located in the State of Maryland adjacent to the U.S. capital city, Washington D.C. The majority of CBA members are Chinese scientists, researchers, or professors working in government agencies, universities, research institutes, and biotechnology and pharmaceutical industries. Among them, many are doing pioneering research with the National Institutes of Health (NIH), and some are directly involved in the government regulatory process as officers of the Food and Drug Administration. CBA's Executive Committee consists of research, regulatory and management professionals representing all sectors of the bio-pharmaceutical research and development institutions as well as regulatory agencies. These committee members have volunteered to contribute their time and skills to the founding and development of CBA. For more information, click HERE.
Inhibox is a drug discovery company that uses computational methods to discover new leads for drugs. The company's technology is based on the leveraging of computing power from individual PCs around the world. It uses novel software developed to screen libraries of molecules to search for suitable drug candidates; this type of software has been the basis of the hugely successful "cancer screensaver" project which now involves over one million PCs in 200 countries. Inhibox will also facilitate the considerable amount of chemical and biological testing that will be necessary to license such candidates to companies capable of exploiting their medicinal properties. For more information, click HERE.
The Programme of Action for Cancer Therapy (PACT) was created by the International Atomic Energy Agency (IAEA) in 2004 in response to the developing world’s growing cancer crisis. PACT aims to help developing countries build a comprehensive, sustainable cancer control programme integrating prevention, screening, treatment and palliative care. For more information, click here.
The mission of Life Line Screening is to make people aware of a previously unrecognized health problem and encourage these individuals to seek follow up care with their physicians. We are dedicated to providing the highest quality preventive screenings at an affordable rate. We offer screenings to detect carotid artery stenosis, atrial fibrillation, systolic hypertension, abdominal aortic aneurysms, peripheral arterial disease and diminished bone density. Our participants are generally age 50 and over and are asymptomatic although they tend to have significant risk factors such as hypertension, hypercholesterolemia, smoking, diabetes mellitus, or a family history of stroke. In certain states, we also do finger-stick blood tests for cholesterol, glucose and C-reactive protein. For more information, click here.
The Prostate Cancer Foundation (PCF) is the world's largest philanthropic source of support for prostate cancer research. Founded in 1993, the PCF has raised more than $300 million and provided funding for prostate cancer research to more than 1,400 researchers at 100 institutions worldwide. The PCF has a simple, yet urgent goal: to find better treatments and a cure for recurrent prostate cancer. For more information, click HERE.  The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen's research is based on personalized medicine. The institute plans to accomplish its goals through robust and disease-focused research. For more information, click HERE. Corporate Sponsors
Our Foundation Partners / Donors share the NFCR commitment to Research for a CURE. 4Charity Foundation We are always looking for more partners, sponsors, and foundations to join us in the fight against cancer. To join NFCR as a partner, sponsor, or foundation, please contact us at 1-800-321-CURE (2873) or via email at This e-mail address is being protected from spambots. You need JavaScript enabled to view it . |
